Direct acting antivirals treatment for hepatitis C virus infection does not increase the incidence of de novo hepatocellular carcinoma occurrence: Results from an Italian real-life cohort (LINA cohort)

The effectiveness of direct-acting antivirals (DAAs) against hepatitis C virus (HCV) infection is ascertained. However, some authors raised the issue of an increased incidence of de novo hepatocellular carcinoma (HCC) in patients treated with DAAs. Aim of the study was to evaluate the rate of HCC oc...

Descripción completa

Detalles Bibliográficos
Autores principales: Buonomo, Antonio Riccardo, Scotto, Riccardo, Coppola, Carmine, Pinchera, Biagio, Viceconte, Giulio, Rapillo, Costanza Maria, Staiano, Laura, Saturnino, Mariarosaria, Scarano, Ferdinando, Portunato, Federica, Pisaturo, Mariantonietta, De Pascalis, Stefania, Martini, Salvatore, Tosone, Grazia, Nappa, Salvatore, Coppola, Nicola, Gentile, Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015572/
https://www.ncbi.nlm.nih.gov/pubmed/32028404
http://dx.doi.org/10.1097/MD.0000000000018948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015572/
https://www.ncbi.nlm.nih.gov/pubmed/32028404
http://dx.doi.org/10.1097/MD.0000000000018948

Ejemplares similares